Marshall Fordyce

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

VERA

Current role

CEO, Board Member

2016-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Vera Therapeutics, Inc. (VERA)	President and Chief Executive Officer	$660,000	—	$2,356,285	$3,415,725	$554,400	—	$6,986,410
2024	Vera Therapeutics, Inc. (VERA)	President and Chief Executive Officer	$616,250	—	$1,323,000	$3,299,751	$409,200	—	$5,648,201
2023	Vera Therapeutics, Inc. (VERA)	President and Chief Executive Officer	$585,638	$32,450	—	$2,519,595	$292,050	—	$3,429,733
2022	Vera Therapeutics, Inc. (VERA)	President and Chief Executive Officer	$551,340	—	$813,750	$2,463,989	$277,550	—	$4,106,629
2021	Vera Therapeutics, Inc. (VERA)	President and Chief Executive Officer	$479,099	—	—	$770,343	$236,259	—	$1,485,701
2020	Vera Therapeutics, Inc. (VERA)	President and Chief Executive Officer	$360,000	—	$316,323	$2,441,982	$108,000	—	$3,226,305

No earnings-call appearances or filed executive changes recorded yet.